These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 2448329
1. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. Suikkari AM, Koivisto VA, Rutanen EM, Yki-Järvinen H, Karonen SL, Seppälä M. J Clin Endocrinol Metab; 1988 Feb; 66(2):266-72. PubMed ID: 2448329 [Abstract] [Full Text] [Related]
4. The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus. Bach MA, Chin E, Bondy CA. J Clin Endocrinol Metab; 1994 Oct; 79(4):1040-5. PubMed ID: 7525624 [Abstract] [Full Text] [Related]
5. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. J Clin Endocrinol Metab; 1994 Sep; 79(3):872-8. PubMed ID: 7521354 [Abstract] [Full Text] [Related]
6. Serum levels of insulin-like growth factor (IGF) and IGF binding protein in insulin-dependent diabetics during an episode of severe metabolic decompensation and the recovery phase. Rieu M, Binoux M. J Clin Endocrinol Metab; 1985 Apr; 60(4):781-5. PubMed ID: 2579089 [Abstract] [Full Text] [Related]
7. Changes in insulin-like growth factor (IGF)-binding proteins after IGF-I injections in noninsulin-dependent diabetics. Young SC, Clemmons DR. J Clin Endocrinol Metab; 1994 Mar; 78(3):609-14. PubMed ID: 7510305 [Abstract] [Full Text] [Related]
8. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus. Janssen JA, Jacobs ML, Derkx FH, Weber RF, van der Lely AJ, Lamberts SW. J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701 [Abstract] [Full Text] [Related]
9. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. Hilding A, Brismar K, Degerblad M, Thorén M, Hall K. J Clin Endocrinol Metab; 1995 Sep; 80(9):2646-52. PubMed ID: 7545695 [Abstract] [Full Text] [Related]
10. Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. Suikkari AM, Koivisto VA, Koistinen R, Seppälä M, Yki-Järvinen H. J Clin Endocrinol Metab; 1989 Jan; 68(1):135-40. PubMed ID: 2462571 [Abstract] [Full Text] [Related]
11. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus. Bereket A, Lang CH, Blethen SL, Gelato MC, Fan J, Frost RA, Wilson TA. J Clin Endocrinol Metab; 1995 Apr; 80(4):1312-7. PubMed ID: 7536205 [Abstract] [Full Text] [Related]
12. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients. Laursen T, Jørgensen JO, Jakobsen G, Hansen BL, Christiansen JS. J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114 [Abstract] [Full Text] [Related]
14. Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus. Brismar K, Gutniak M, Povoa G, Werner S, Hall K. J Endocrinol Invest; 1988 Sep; 11(8):599-602. PubMed ID: 2468706 [Abstract] [Full Text] [Related]
15. Immunoreactive proinsulin-like growth factor-II levels in healthy subjects, patients with growth hormone deficiency, and patients with type 1 diabetes: effects of insulin-like growth factor-I and insulin. Tally M, Eriksson U, Thorén M, Brismar K, Hall K. J Clin Endocrinol Metab; 1994 Dec; 79(6):1576-81. PubMed ID: 7989458 [Abstract] [Full Text] [Related]
16. The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity. Clemmons DR, Moses AC, McKay MJ, Sommer A, Rosen DM, Ruckle J. J Clin Endocrinol Metab; 2000 Apr; 85(4):1518-24. PubMed ID: 10770191 [Abstract] [Full Text] [Related]
17. Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor-binding protein: control by nutritional variables. Busby WH, Snyder DK, Clemmons DR. J Clin Endocrinol Metab; 1988 Dec; 67(6):1225-30. PubMed ID: 2461386 [Abstract] [Full Text] [Related]
18. Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications. Muñoz MT, Barrios V, Pozo J, Argente J. Pediatr Res; 1996 Jun; 39(6):992-8. PubMed ID: 8725260 [Abstract] [Full Text] [Related]
19. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects. Pratipanawatr T, Pratipanawatr W, Rosen C, Berria R, Bajaj M, Cusi K, Mandarino L, Kashyap S, Belfort R, DeFronzo RA. Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1360-8. PubMed ID: 12006367 [Abstract] [Full Text] [Related]
20. Effects of glucocorticoids on circulating levels and hepatic expression of insulin-like growth factor (IGF)-binding proteins and IGF-I in the adrenalectomized streptozotocin-diabetic rat. Unterman TG, Jentel JJ, Oehler DT, Lacson RG, Hofert JF. Endocrinology; 1993 Dec; 133(6):2531-9. PubMed ID: 7694841 [Abstract] [Full Text] [Related] Page: [Next] [New Search]